Iradimed (IRMD) EBT Margin (2013 - 2026)

Iradimed (IRMD) has 14 years of EBT Margin data on file, last reported at 35.35% in Q1 2026.

• EBT Margin for Q1 2026 came in at 35.35%, up 488.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 34.98% (up 175.0% YoY), and the FY2025 annual result was 33.84%, up 69.0% from the prior year.
• EBT Margin improved to 35.35% in Q1 2026 per IRMD's latest filing, from 34.33% in the prior quarter.
• Over five years, EBT Margin peaked at 38.83% in Q3 2023 and troughed at 24.86% in Q1 2022.
• A 5-year average of 32.72% and a median of 32.85% in 2023 frame the typical range for EBT Margin.
• The sharpest annual moves came in 2022 and 2024: EBT Margin soared 1392 bps in 2022, then tumbled 381 bps in 2024.
• A 5-year view of EBT Margin shows it stood at 31.64% in 2022, then rose by 3 bps to 32.56% in 2023, then gained by 1 bps to 32.72% in 2024, then increased by 5 bps to 34.33% in 2025, then increased by 3 bps to 35.35% in 2026.
• Business Quant data shows IRMD's EBT Margin at 35.35% in Q1 2026, 34.33% in Q4 2025, and 34.42% in Q3 2025.